Cargando…
Chronotherapy in COVID-19 Disease
Autores principales: | LACOUT, Alexis, MARCY, Pierre Yves, PERRONNE, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997534/ https://www.ncbi.nlm.nih.gov/pubmed/33772438 http://dx.doi.org/10.1007/s11606-021-06719-3 |
Ejemplares similares
-
Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Lacout, Alexis, et al.
Publicado: (2021) -
The Persistent Lyme Disease: “True Chronic Lyme Disease” rather than “Post-treatment Lyme Disease Syndrome”
por: Lacout, Alexis, et al.
Publicado: (2018) -
Favorable Outcome after Treatment Using Antibiotics and Hydroxychloroquine in a Patient with Tumor Necrosis Factor Receptor-associated Periodic Syndrome: A 7-Year Follow-Up
por: Galperine, Tatiana, et al.
Publicado: (2020) -
Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients
por: Lacout, Alexis, et al.
Publicado: (2021) -
RE: Role of Duplex Doppler US for Thyroid Nodules: Looking for the "Sword" Sign
por: Lacout, Alexis, et al.
Publicado: (2011)